Transition [comd]
Raloxifene [orch, phsu]
Low dose [qnco]
estrogen therapy [topp]
postmenopausal [tmco]
Women [popg]
effects [qlco]
Serum lipids NOS [lbpr]
Fibrinogen [aapp, bacs, phsu]
Pilot [prog]
Study [mnob]
Objective [inpr]
Compare [acty]
effects [qlco]
Transferring [acty]
Low dose [qnco]
transdermal estrogen [horm, phsu, strd]
Raloxifene [orch, phsu]
Phase [tmco]
alternate day [tmco]
Raloxifene [orch, phsu]
therapy [ftcn]
Low dose [qnco]
transdermal estrogen [horm, phsu, strd]
Serum lipids NOS [lbpr]
Fibrinogen [aapp, bacs, phsu]
postmenopausal [tmco]
Women [popg]
Administered [ftcn]
estrogen therapy [topp]
Plus [qlco]
Progestagen [horm, phsu, strd]
Methods [inpr]
postmenopausal [tmco]
Women [popg]
Mean [qnco]
Age-Years [tmco]
randomized [resa]
One [qnco]
Two [qnco]
treatment [ftcn]
Group [idcn]
Raloxifene [orch, phsu]
Low dose [qnco]
transdermal estrogen [horm, phsu, strd]
Raloxifene [orch, phsu]
Raloxifene [orch, phsu]
placebo [topp]
Study [mnob]
Four [qnco]
Phases [tmco]
Phase [tmco]
I- [inch]
Subject [grup]
Low dose [qnco]
transdermal estrogen [horm, phsu, strd]
Phase [tmco]
Ii [aapp]
DOUBLE BLIND [resa]
Combination [qlco]
Low dose [qnco]
transdermal estrogen [horm, phsu, strd]
placebo [topp]
Phase [tmco]
III [inpr]
Subject [grup]
placebo [topp]
Phase [tmco]
Subject [grup]
placebo [topp]
Result [ftcn]
Exist [cnce]
Group [idcn]
baseline [bodm]
measurements [ftcn]
Phase [tmco]
I- [inch]
Phase [tmco]
I- [inch]
Subject [grup]
Combined [qlco]
Total Cholesterol [lbpr]
Low cholesterol [fndg]
density [qnco]
Show [inpr]
Increase [ftcn]
median [spco]
Increase [ftcn]
mmol/L [qnco]
P NOS [aapp, imft]
mmol/L [qnco]
P NOS [aapp, imft]
Triglycerides [bacs, lipd]
Decreased [qnco]
median [spco]
Decrease [qlco]
mmol/L [qnco]
P NOS [aapp, imft]
Primary [qlco]
Analysis [lbpr]
Phase [tmco]
Ii [aapp]
Phase [tmco]
Mean [qnco]
Change [ftcn]
baseline [bodm]
observations [resa]
Show [inpr]
therapy [ftcn]
Group [idcn]
Serum lipids NOS [lbpr]
Fibrinogen [aapp, bacs, phsu]
Vital signs [clna]
weight [orga]
Comparison [acty]
Phase [tmco]
Phase [tmco]
Ii [aapp]
Change [ftcn]
Serum lipids NOS [lbpr]
Fibrinogen [aapp, bacs, phsu]
Vital signs [clna]
weight [orga]
Not [ftcn]
Different [qlco]
Group [idcn]
Conclusion [idcn]
Gradual [qlco]
Conversion [ftcn]
Raloxifene [orch, phsu]
Low dose [qnco]
transdermal estrogen [horm, phsu, strd]
Phase [tmco]
alternate day [tmco]
Raloxifene [orch, phsu]
therapy [ftcn]
Low dose [qnco]
transdermal estrogen [horm, phsu, strd]
Not [ftcn]
Effect [qlco]
serum lipid [lbpr]
Profile [lbpr]
Fibrinogen level [lbpr]
